134 related articles for article (PubMed ID: 2573370)
21. Renal and limb vasodilatation during acute beta-adrenoceptor blockade with indenolol.
Poggesi L; Bisi G; La Cava G; Sciagra R; Del Rosso A; Masotti G
J Clin Pharmacol; 1995 Feb; 35(2):176-81. PubMed ID: 7751429
[TBL] [Abstract][Full Text] [Related]
22. Tertatolol preserves renal perfusion in patients with arterial hypertension after head injury.
Leeman M; Naeije R; Degaute JP; Brackman F; Thomas J; Prost JF
Am J Nephrol; 1986; 6 Suppl 2():36-9. PubMed ID: 2879471
[TBL] [Abstract][Full Text] [Related]
23. Preserving the autoregulation of renal hemodynamics.
Beaufils M
Cardiology; 1993; 83 Suppl 1():10-5. PubMed ID: 7903210
[TBL] [Abstract][Full Text] [Related]
24. Vasodilator effect of tertatolol in isolated perfused rat kidneys: involvement of endothelial 5-HT1A receptors.
Verbeuren TJ
Cardiology; 1993; 83 Suppl 1():5-9. PubMed ID: 7903215
[TBL] [Abstract][Full Text] [Related]
25. Acute central and renal haemodynamic responses to tertatolol and propranolol in patients with arterial hypertension following head injury.
Leeman M; Naeije R; Degaute JP; Brackman F; Prost JF
J Hypertens; 1986 Oct; 4(5):581-7. PubMed ID: 2878953
[TBL] [Abstract][Full Text] [Related]
26. Comparative renal and cardiac effects of tertatolol and enalapril in essential hypertension.
Ribstein J; Du Cailar G; Brouard R; Mimran A
Cardiology; 1993; 83 Suppl 1():57-63. PubMed ID: 7903217
[TBL] [Abstract][Full Text] [Related]
27. Role of baroreflex activation in the regional hemodynamic effects of the beta-blockers tertatolol and propranolol in conscious spontaneously hypertensive rats.
Struyker-Boudier HA; van Essen H; Nievelstein HM; Smits JF
Am J Nephrol; 1986; 6 Suppl 2():25-9. PubMed ID: 2879469
[TBL] [Abstract][Full Text] [Related]
28. [Vasodilator effect of tertatolol on isolated rat kidney].
Stephan D; Barthelmebs M; Rochat C; Imbs JL
Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1211-3. PubMed ID: 2573324
[TBL] [Abstract][Full Text] [Related]
29. High beta 1-selectivity and favourable pharmacokinetics as the outstanding properties of bisoprolol.
Haeusler G; Schliep HJ; Schelling P; Becker KH; Klockow M; Minck KO; Enenkel HJ; Schulze E; Bergmann R; Schmitges CJ
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S2-15. PubMed ID: 2439793
[TBL] [Abstract][Full Text] [Related]
30. Effect of tertatolol and of its metabolites and structural analogues in isolated perfused rat kidney vasculature.
Stephan D; Barthelmebs M; Krieger JP; Decker N; Rochat C; Imbs JL
J Cardiovasc Pharmacol; 1990 Aug; 16(2):338-46. PubMed ID: 1697392
[TBL] [Abstract][Full Text] [Related]
31. Beta blockers and renal function: a reappraisal.
Epstein M; Oster JR
J Clin Hypertens; 1985 Mar; 1(1):85-99. PubMed ID: 2873206
[TBL] [Abstract][Full Text] [Related]
32. Additional benefits of combining beta-blockade and renal vasodilation in the treatment of mild to moderate hypertension: Tertatolol International Multicentre Study results.
Agnes E; Prost JF; Laher MS
J Hypertens Suppl; 1989 Dec; 7(6):S270-1. PubMed ID: 2576668
[No Abstract] [Full Text] [Related]
33. Study of prejunctional beta-adrenoceptors in kidneys of normotensive and hypertensive rats using the new beta-adrenoceptor blocking drug tertatolol.
Verbeuren TJ; Herman AG
Am J Nephrol; 1986; 6 Suppl 2():30-5. PubMed ID: 2879470
[TBL] [Abstract][Full Text] [Related]
34. Cardiac and renovascular effects in the anaesthetized dog of BW A575C: a novel angiotensin converting enzyme inhibitor with beta-adrenoceptor blocking properties.
Cambridge D; Whiting MV; Allan G
Br J Pharmacol; 1988 Jan; 93(1):165-75. PubMed ID: 2894874
[TBL] [Abstract][Full Text] [Related]
35. Effect of tertatolol on glomerular hemodynamics in the normal Munich-Wistar rat.
Gabbai FB; Peterson OW; Prost JF; Blantz RC
Am J Hypertens; 1989 Nov; 2(11 Pt 2):213S-218S. PubMed ID: 2573366
[TBL] [Abstract][Full Text] [Related]
36. Mode of action of beta-adrenergic blocking drugs in hypertension.
Prichard BN; Owens CW
Clin Physiol Biochem; 1990; 8 Suppl 2():1-10. PubMed ID: 1982756
[TBL] [Abstract][Full Text] [Related]
37. Recent advances in beta blockade. Therapeutic implications in hypertension. Proceedings of the First International Symposium on Tertatolol, 15th June, 1985, Milano, Italy.
Am J Nephrol; 1986; 6 Suppl 2():1-116. PubMed ID: 2879463
[No Abstract] [Full Text] [Related]
38. Overview of clinical safety and efficacy of tertatolol.
Vivet P
Cardiology; 1993; 83 Suppl 1():41-50. PubMed ID: 7903214
[TBL] [Abstract][Full Text] [Related]
39. Chronic carvedilol reduces mortality and renal damage in hypertensive stroke-prone rats.
Barone FC; Nelson AH; Ohlstein EH; Willette RN; Sealey JE; Laragh JH; Campbell WG; Feuerstein GZ
J Pharmacol Exp Ther; 1996 Nov; 279(2):948-55. PubMed ID: 8930204
[TBL] [Abstract][Full Text] [Related]
40. [Influence of 3 beta-blockers on the diameter of glomeruli isolated from the renal cortex of rats].
Brondeau P; Martin-Dupont P; Cambar J
C R Seances Soc Biol Fil; 1985; 179(1):98-101. PubMed ID: 2862977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
